Charlie Garnett Benson, PhD
About Charlie Garnett Benson, PhD
Charlie Garnett Benson, PhD, is the Senior Scientific Director and Translational Medicine Team Lead at Bristol Myers Squibb in Princeton, New Jersey, and Founder of BeyondTheCodon in Greater Atlanta Area.
Title and Role at Bristol Myers Squibb
Charlie Garnett Benson, PhD, currently serves as the Senior Scientific Director and Translational Medicine Team Lead at Bristol Myers Squibb in Princeton, New Jersey. This role entails guiding the direction of translational medicine initiatives, aligning scientific and clinical strategies to enhance patient outcomes.
Educational Background and Expertise
Charlie Garnett Benson obtained a Doctor of Philosophy (PhD) in Immunology and Molecular Pathogenesis from Emory University, completing the program in 2002. His expertise encompasses tumor immunology, cancer immunotherapy, and the mechanisms of immune responses to cancer treatments. He has received a Cancer Research Training Award (CRTA) fellowship from the National Cancer Institute, which supported his work on integrating recombinant pox-viral tumor vaccines with other therapeutic modalities.
Academic Positions and Research at Georgia State University
Throughout his tenure at Georgia State University, Charlie Garnett Benson held several roles, including Lecturer, Assistant Professor, Tenured Associate Professor, and Associate Director for Research. He developed and taught courses on Tumor Immunology & Cancer Immunotherapy and led an independent academic research group focused on mechanisms of enhanced immune attack against tumor cells post-radiation therapy. His research included pre-clinical models of colorectal, breast, and other solid tumors, and he was a recipient of grants from NIH, the Children’s Leukemia Research Association, and the American Cancer Society.
Previous Roles in Translational Medicine and Consulting
Before his current position, Charlie Garnett Benson served as the Scientific Director at Bristol Myers Squibb from 2019 to 2021, where he contributed significantly to translational medicine projects. He also worked as a Scientific Consultant at Medscape in 2017. His varied roles provided him with extensive experience in both clinical research and scientific consultation.
Founding of BeyondTheCodon
Charlie Garnett Benson is the Founder of BeyondTheCodon, a company based in the Greater Atlanta Area. Through this venture, he seeks to bridge gaps in scientific research and its translation to clinical applications, leveraging his extensive expertise in immunology and molecular pathogenesis to foster innovative therapeutic approaches.